drug
EPHEDRINE SULFATE
Marketedupdated 3mo agoby Fresenius Kabi USA LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 4all catalysts(1)
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jan 22, 2040
~13.4 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (10)
- May 16, 2040method-of-use (U-3183)US 11090278
- May 16, 2040method-of-use (U-3183)US 11241400
- May 16, 2040formulationUS 11464752
- May 16, 2040formulationUS 11464752
- May 16, 2040method-of-use (U-3183)US 11478436
- May 16, 2040method-of-use (U-3183)US 11571398
- May 16, 2040method-of-use (U-3183)US 11571398
- Jan 22, 2040formulationUS 10869845
- Jan 22, 2040formulationUS 10869845
- Jan 22, 2040method-of-use (U-3963)US 12029710
FDA exclusivities (2)
- Feb 21, 2026PCPC
- Feb 21, 2026PCPC
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 7m ago
Found something off?
comments(0)
5-min edit window · permanent after that